Journal
AMERICAN JOURNAL OF SURGICAL PATHOLOGY
Volume 36, Issue 2, Pages 283-291Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/PAS.0b013e318235ee03
Keywords
MCM6; Ki-67; cyclin D1; meningioma; atypical meningioma
Ask authors/readers for more resources
The 2007 World Health Organization histologic grading of meningiomas is associated with recurrence and clinical outcome. However, distinction of grade I from grade II (atypical) meningiomas can be challenging. In the World Health Organization classification, there are 4 parameters on the basis of which grade II status can be determined: mitotic rate, cytoarchitectural features, brain invasion, and/or histologic subtype. Furthermore, this classification fails to detect grade I recurrent meningiomas, for which other prognostic criteria would be needed. The aim of this study was to evaluate the respective value of several markers involved in cell cycle as effective tools to predict recurrence. This retrospective study was based on a series of 59 meningiomas (grade I: 32 of 59, grade II: 27 of 59, all harboring >= 4 mitoses/1.6 mm(2)), analyzed with the following immunohistochemical markers: MCM6, Ki-67, PHH3, cyclin D1, and p53. We found a significant correlation between histologic grade and mean labeling index for MCM6 (grade I: 21.8% vs. grade II: 65.8%; P < 0.001), Ki-67 (3.2% vs. 16.9%; P < 0.001), PHH3 (0.7 parts per thousand vs. 2.8 parts per thousand; P < 0.001), cyclin D1 (50.4% vs. 70.0%; P = 0.005), and p53 (17.3% vs. 32.4%; P = 0.017). Histologic grading and mitotic index were correlated with progression-free survival (P = 0.010 and P = 0.020, respectively). A nearly linear correlation was found between progression-free survival and staining for MCM6 (P < 0.001), Ki-67 (P = 0.003), and PHH3 (P = 0.037) but not for cyclin D1 (P = 0.400) and p53 (P = 0.758). The interobserver agreement coefficients for MCM6, Ki-67, PHH3, cyclin D1, and p53 were, respectively, 0.97 (95% confidence interval, 0.95-0.98), 0.93 (0.89-0.96), 0.81 (0.70-0.88), 0.90 (0.83-0.94), and 0.84 (0.73-0.90). In conclusion, because of its strong level of expression and sharp difference in labeling index between indolent and recurrent tumors, MCM6 is the most efficient marker to identify tumors with a high risk of recurrence.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available